Targeting nuclear factor erythroid 2-related factor 2-regulated ferroptosis to treat nervous system diseases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=0

Nov 26, 2024 (publication date) through Sep 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Clin Cases. Nov 26, 2024; 12(33): 6655-6659
Published online Nov 26, 2024. doi: 10.12998/wjcc.v12.i33.6655

Full Size Figure Download Figure

Figure 1 Illustration of representative lipid nanoparticles, polymeric nanoparticles, and protein nanoparticles.

Citation: Huang YQ, Huang ZW, Zhang XJ. Targeting nuclear factor erythroid 2-related factor 2-regulated ferroptosis to treat nervous system diseases. World J Clin Cases 2024; 12(33): 6655-6659
URL: https://www.wjgnet.com/2307-8960/full/v12/i33/6655.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i33.6655